• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITHS MEDICAL ASD, INC. CADD-LEGACY DUODOPA AMBULATORY INFUSION PUMP; PUMP, INFUSION, ENTERAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITHS MEDICAL ASD, INC. CADD-LEGACY DUODOPA AMBULATORY INFUSION PUMP; PUMP, INFUSION, ENTERAL Back to Search Results
Model Number 1400
Device Problems Use of Device Problem (1670); Human-Device Interface Problem (2949)
Patient Problem Dyskinesia (2363)
Event Type  Injury  
Event Description
Information was received indicating that a patient using a smiths medical cadd-legacy duodopa ambulatory infusion pump received an overdose of duodopa.It was reported that the patient was suspected of adjusting the pump rates.Per reporter, the pump was on lock level one and was programmed to an upper limit of 2.2ml; however, the pump could still be manually set higher and it was found that the continuous dose was set on 3.7 ml/hour.Per reporter the dose was subsequently changed to 2.2 ml/hour.It was reported that the patient experienced severe dyskinesia and was hospitalized as a precaution and no further medical intervention was planned.It was reported that the pump was "stopped, as usual for the night.The next day was started up again at the correct dosage." it was also reported that the patient had a "very small therapeutic window for l-dopa.".
 
Manufacturer Narrative
Other, other text: device evaluation: one smiths medical cadd-legacy duodopa ambulatory infusion pump was returned for analysis in used condition.Visual inspection showed no physical damage on the pump.The reported error message lec 1816 was not found at power up or in the event history log.In addition the event history log showed numerous changings of the "delivery rate," on (b)(6) 2020 the highest rate concerning the "morning dose" was 3,0 ml/h and highest rate concerning "continuous dose" was 2.1 ml/h in contrast to the reported "continuous dosage was set on 3.7ml/h." the pump was found to be operating properly and passed all tests.Based on the investigation, the complaint allegation was not confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CADD-LEGACY DUODOPA AMBULATORY INFUSION PUMP
Type of Device
PUMP, INFUSION, ENTERAL
Manufacturer (Section D)
SMITHS MEDICAL ASD, INC.
6000 nathan lane north
minneapolis MN 55442
MDR Report Key10477046
MDR Text Key205121667
Report Number3012307300-2020-08879
Device Sequence Number1
Product Code LZH
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 10/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/01/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model Number1400
Device Catalogue Number21-1400-06
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received09/30/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-